Go to main content

Solvable Problems in Diabetes at ATTD 2023

With the advancements in Continuous Glucose Monitoring and Time in Range, we find ourselves at a transformational moment in the care of people with diabetes. Researchers, engineers, and clinicians around the world are dedicating their lives to advance this technology and further improve the daily lives and long-term health of people with T1D, T2D, and pre-diabetes. Four esteemed women at the forefront of diabetes care, research, and advocacy, joined by Professor Tadej Battelino, will discuss what the future holds, and the challenges before us, at this exciting junction in time.  Panelists include Prof. Chantal Mathieu (Katholieke Universiteit, Leuven, Belgium), Prof. Ananta Addala (Stanford University, USA), Prof. Elaine YK Chow (Chinese University of Hong Kong, Hong Kong SAR), and Prof. Emma Wilmot (University of Nottingham, UK).

Join us at an elegant historic setting for food, drink, and an evening of exceptional networking and learning. 

This is a ticketed event and space is limited. Discounted tickets for other clinicians, researches, and advocates. A limited number for complimentary tickets are available for event sponsors (below) and for ATTD Faculty, contact Rachel Allen for more information.



 Tadej Battelino, MD, PhDUCH, University Medical Center, Ljubljana, Slovenia Professor, Faculty of Medicine, University of Ljubljana Co-chair and organizer of ATTD, Tadej Battelino completed his medical degree at the University of Ljubljana in 1990. He completed a PhD focusing on glucose metabolism in neonatal endotoxic shock in 1996. He completed his clinical fellowship at Loyola University of Chicago, USA, and his postdoctoral fellowship at INSERM, Paris, France.

Professor Battelino is currently Consultant and Head of Department of Pediatric and Adolescent Endocrinology, UMC Ljubljana, Head, Chair of Pediatrics, and Professor of Pediatrics at Faculty of Medicine, University of Ljubljana. He is PI on several publicly funded research projects in the field of diabetes, endocrinology and metabolism, and was awarded the Slovene national award for research in 2014, Gold medal for research at the University of Ljubljana in 2017, the ISPAD Achievement Award in 2020, and the Presidential Medal from Children with Diabetes society in 2022. Professor Battelino serves on the editorial boards for the journals Diabetes Care, Journal of Pediatric Endocrinology and Metabolism, Acta Diabetologica, and was Editor for the European Journal of Endocrinology from 2009 to 2015. He has authored or co-authored over 329 papers in international peer-reviewed journals and participated in chapters to several international books. He has a cumulative h index of 61. 

Professor Battelino is a member of numerous professional associations including the American Diabetes Association (ADA), European Society for Paediatric Endocrinology (ESPE) and the International Society for Pediatric and Adolescent Diabetes (ISPAD), for which he served as President for the 35th Annual Congress. He served on the European Association for the Study of Diabetes (EASD) council and is co-organizer of sixteen annual meetings of the Advanced Technologies and Treatment of Diabetes - ATTD. He serves as Chair-Elect International Diabetes Federation – Europe (IDF-EU). He is an elected Honorary member of the Italian Society for Pediatric Endocrinology and Diabetology (SIEDP) and the Hellenic Society of Pediatric and Adolescent Endocrinology (EEPEE).  Professor Battelino is a member of the Slovenian Medical Academy, Slovenian Academy of Sciences and Arts (SAZU),  and the European Academy of Sciences and Arts.



Chantal Mathieu, MD, PhD

Professor of Medicine at the Katholieke Universiteit, Leuven, Belgium
Chair of Endocrinology at the University Hospital Gasthuisberg Leuven

Professor Chantal Mathieu is a physician-scientist who has contributed to the field of diabetes and endocrinology through basic and clinical research. Her basic research work focuses on pathogenesis and prevention of type 1 diabetes. Prof. Mathieu’s clinical work involving new products and treatment paradigms in diabetes, such as new insulins, adjunct therapies, and diagnosis of gestational diabetes have made her a speaker in international fora. Prof. Mathieu coordinates the European project ‘INNODIA’ on biomarker discovery and intervention studies in type 1 diabetes. Prof. Mathieu is president of EASD and vice-president of the European Diabetes Forum.


Ananta Addala, DO, MPH
Assistant Professor, Stanford University, USA

Professor Ananta Addala is a pediatric endocrinologist and physician scientist at Stanford University addressing disparities in pediatric type 1 diabetes management and outcomes. As a physician with a background in pediatric endocrinology, epidemiology, and behavioral health, she aims to build an evidence-based approach to addressing T1D disparities by systematically evaluating youth-, family-, provider-, and system-level barriers to optimal diabetes care in youth from low socioeconomic and racial/ethnic minority groups. She is funded by NIDDK K23 to understand and address disparities in pediatric diabetes technology access and utilization. She also has funding from the Maternal Child Research Institute and Helmsley Charitable Trust. To date, her publications have demonstrated that the disparities in pediatric T1D by socioeconomic status are worsening in the US, provider bias against public insurance is common, and public insurance mediated interruptions to diabetes technology adversely impact glycemic outcomes. She has also been leading the efforts to improve justice, equity, diversity, and inclusion in research at Stanford University through her leadership at Stanford Pediatrics Advancing Anti-Racism Coalition and as the co-chair of TrialNet's Underrepresented Minorities Outreach Committee.

 Elaine Chow, MBChB, MSc, PhD, MRCP, FHKAM 

Clinical Assistant Professor, Deputy Medical Director, Department of Medicine and Therapeutics,
Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong SAR 

Professor Elaine Chow received her medical training in the UK and completed her PhD on cardiovascular effects of hypoglycaemia with Prof. Simon Heller at University of Sheffield in 2015. She has since joined the Chinese University of Hong Kong with Prof Juliana Chan and her group, where she helped set up glucose clamp and sensor evaluation studies at the Phase 1 Clinical Trial Center. She secured a number of external grants, and currently leads clinical trials on use of CGM in prediabetes, advanced chronic kidney disease, and peritoneal dialysis. In particular, she is interested in the use of CGM to evaluate basal insulins as well as other drug and non-drug interventions. She has been principal investigator or co-investigator for over 70 Phase 1 to 4 studies relating to cardiometabolic drugs. She has published over 100 peer-reviewed articles, including articles in Diabetes Care, Diabetes, and Nature Reviews Endocrinology. She has also received several awards, including the Hong Kong College of Physicians Richard Yu Lecture and Women’s Interprofessional Network of the American Diabetes Association abstract award in 2022. In addition to teaching and research, she is associate editor and editorial board member for several journals.

 Emma Wilmot, MB, ChB, BSc (hons), PhD, FRCP

Associate Professor, University of Nottingham
Honorary Consultant Diabetologist, University Hospitals of Derby and Burton NHS FT
Founder, Diabetes Technology Network UK

Emma Wilmot is an Associate Professor at the University of Nottingham, Consultant Diabetologist in Derby, and founder of the Diabetes Technology Network UK. She has over 100 publications and has been principal or chief investigator on a range of diabetes studies. She was previously awarded the University of Leicester medal for excellent PhD performance “Type 2 diabetes in younger adults”. As founder of the award-winning Association of British Clinical Diabetologists (ABCD) Diabetes Technology Network UK, she led the organisation to support improvements in access to diabetes technology in the UK, developing and delivering policies and educational resources for both health care professionals and people living with diabetes. Emma is an ABCD committee member, deputy lead for the ABCD audit programme and ABCD academic sub-committee member. She is also a DAFNE structured education executive board member and expert advisor for the National Diabetes Audit programme. Emma is regularly invited to deliver national and international lectures.

 See Information on Past Solvable Problems in Diabetes EventsSolvable Problems at EASD 2022Solvable Problems at EASD 2021

Thank you to our sponsors for making this event possible


Platinum Sponsors



Gold Sponsors



Silver Sponsors




Bronze Sponsor